跳至主要内容
临床试验/NCT05758766
NCT05758766进行中(未招募)不适用

A Feasibility Study on the Use of Plant Based Omega-3-Fatty Acids (Flaxseed) to Improve Inflammation Driven Pain Outcomes in Children With Sickle Cell Anemia

University of Alabama at Birmingham1 个研究点 分布在 1 个国家目标入组 30 人开始时间: 2023年8月30日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
进行中(未招募)
入组人数
30
试验地点
1
主要终点
Acute pain

研究概览

简要总结

Sickle cell disease (SCD) is associated with significant morbidity and mortality. Pain and many adverse outcomes occurring in sickle cell disease are inflammatory driven. Recent data has shown that gut dysbiosis is present in individuals with sickle cell disease. Gut dysbiosis has been linked to inflammation in certain diseases. Omega -3-fatty acids (fish oil) has been shown to improve pain outcomes in individuals with sickle cell disease, but its acceptance is variable. The aim of this study is to determine if a plant-based omega-3-fatty acids will be more acceptable and also improve outcomes in individuals with sickle cell disease

详细描述

Sickle cell disease (SCD) is associated with significant morbidity and mortality. Pain and many adverse outcomes occurring in sickle cell disease are inflammatory driven. Recent data has shown that gut dysbiosis is present in individuals with sickle cell disease. Gut dysbiosis has been linked to inflammation in certain diseases. Omega -3-fatty acids (fish oil) has been shown to improve pain outcomes in individuals with sickle cell disease, but its acceptance is variable. The aim of this study is to determine if a plant-based omega-3-fatty acids will be more acceptable and also improve outcomes in individuals with sickle cell disease.

Children aged 5-18 years will be randomized to receive a diet rich in omega-3-fatty acids versus a regular diet for 12 weeks after which there will be a cross over of arms after a 4-week wash out period. We will compare outcomes (including patient reported pain outcomes and improvement in inflammation markers) while on the omega-3 fatty acid rich diet.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Crossover
主要目的
Treatment
盲法
Double (Participant, Investigator)

盲法说明

Both principal investigator and participants will be blinded to arm of study

入排标准

年龄范围
5 Years 至 18 Years(Child, Adult)
性别
All
接受健康志愿者

入选标准

  • Diagnosis of sickle cell anemia HbSS or HbSB0 thal at steady state
  • Age 5-18 years old

排除标准

  • Age less than 5 years
  • Age > 18 years old
  • Chronic transfusion therapy
  • Known to be pregnant
  • Breastfeeding mothers
  • Current use of antibiotics
  • Use of pre or probiotic supplements
  • PPI therapy
  • Known allergy to FS

研究组 & 干预措施

Regular diet

No Intervention

Participants will continue their regular diet.

Plant based omega 3 Fatty Acid

Experimental

Participants ingest their regular diet supplemented with a plant-based omega-3-FA

干预措施: Plant-based omega-3-FA (Dietary Supplement)

结局指标

主要结局

Acute pain

时间窗: 12 weeks

Decrease in acute pain frequency measured with weekly pain diaries and acute care visits for pain

Chronic pain

时间窗: 12 weeks

Improvement in quality of life measured using a validated questionnaire

次要结局

  • Inflammation(12 weeks)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Chinenye Dike

Assistant Professor of Pediatrics, Division of Pediatric Gastroenterology, Hepatology and Nutrition

University of Alabama at Birmingham

研究点 (1)

Loading locations...

相似试验